| Name | Title | Contact Details |
|---|
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it`s Series B financing round which will support the advancement of Edgewise Therapeutic`s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company`s pipeline. The company`s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.
Mylan Specialty is a Basking Ridge, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Dracen is a privately funded biotech company developing drugs in the area in of immuno metabolism.
New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods.
Development Chemicals is a Atlantic Highlands, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.